Elevance Health Retained Earnings (Accumulated Deficit) 2010-2024 | ELV
Elevance Health retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Elevance Health retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $34.575B, a 9.39% increase year-over-year.
- Elevance Health retained earnings (accumulated deficit) for 2023 were $31.749B, a 7.09% increase from 2022.
- Elevance Health retained earnings (accumulated deficit) for 2022 were $29.647B, a 9.45% increase from 2021.
- Elevance Health retained earnings (accumulated deficit) for 2021 were $27.088B, a 13.81% increase from 2020.
| Elevance Health Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $31,749 |
| 2022 | $29,647 |
| 2021 | $27,088 |
| 2020 | $23,802 |
| 2019 | $22,573 |
| 2018 | $19,988 |
| 2017 | $18,054 |
| 2016 | $16,561 |
| 2015 | $14,779 |
| 2014 | $14,014 |
| 2013 | $13,814 |
| 2012 | $12,647 |
| 2011 | $11,491 |
| 2010 | $10,722 |
| 2009 | $9,599 |
| Elevance Health Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-06-30 | $34,575 |
| 2024-03-31 | $33,088 |
| 2023-12-31 | $31,749 |
| 2023-09-30 | $32,103 |
| 2023-06-30 | $31,608 |
| 2023-03-31 | $30,707 |
| 2022-12-31 | $29,647 |
| 2022-09-30 | $29,604 |
| 2022-06-30 | $28,825 |
| 2022-03-31 | $28,058 |
| 2021-12-31 | $27,088 |
| 2021-09-30 | $26,700 |
| 2021-06-30 | $25,874 |
| 2021-03-31 | $24,793 |
| 2020-12-31 | $23,802 |
| 2020-09-30 | $24,678 |
| 2020-06-30 | $25,346 |
| 2020-03-31 | $23,360 |
| 2019-12-31 | $22,573 |
| 2019-09-30 | $22,104 |
| 2019-06-30 | $21,679 |
| 2019-03-31 | $21,136 |
| 2018-12-31 | $19,988 |
| 2018-09-30 | $20,182 |
| 2018-06-30 | $19,757 |
| 2018-03-31 | $19,241 |
| 2017-12-31 | $18,054 |
| 2017-09-30 | $17,307 |
| 2017-06-30 | $17,667 |
| 2017-03-31 | $17,358 |
| 2016-12-31 | $16,561 |
| 2016-09-30 | $16,364 |
| 2016-06-30 | $15,918 |
| 2016-03-31 | $15,310 |
| 2015-12-31 | $14,779 |
| 2015-09-30 | $14,762 |
| 2015-06-30 | $14,352 |
| 2015-03-31 | $14,150 |
| 2014-12-31 | $14,014 |
| 2014-09-30 | $13,864 |
| 2014-06-30 | $13,744 |
| 2014-03-31 | $14,012 |
| 2013-12-31 | $13,814 |
| 2013-09-30 | $14,041 |
| 2013-06-30 | $13,818 |
| 2013-03-31 | $13,275 |
| 2012-12-31 | $12,647 |
| 2012-09-30 | $12,557 |
| 2012-06-30 | $12,224 |
| 2012-03-31 | $11,921 |
| 2011-12-31 | $11,491 |
| 2011-09-30 | $11,573 |
| 2011-06-30 | $11,418 |
| 2011-03-31 | $11,200 |
| 2010-12-31 | $10,722 |
| 2010-09-30 | $10,582 |
| 2010-06-30 | $9,998 |
| 2010-03-31 | $9,796 |
| 2009-12-31 | $9,599 |
| 2009-09-30 | $7,127 |
| 2009-06-30 | $6,640 |
| 2009-03-31 | $5,971 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $125.093B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $45.021B | 17.20 |
| ICON (ICLR) | Ireland | $24.951B | 22.42 |
| DiDi Global (DIDIY) | China | $18.956B | 0.00 |
| Avantor (AVTR) | United States | $18.396B | 27.90 |
| Natera (NTRA) | United States | $15.720B | 0.00 |
| Revvity (RVTY) | United States | $15.367B | 26.91 |
| Viatris (VTRS) | United States | $14.203B | 4.33 |
| CochLear (CHEOY) | Australia | $12.751B | 0.00 |
| Solventum (SOLV) | United States | $12.458B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.201B | 33.99 |
| Charles River Laboratories (CRL) | United States | $10.641B | 20.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.811B | 0.00 |
| Doximity (DOCS) | United States | $7.438B | 47.13 |
| Bausch + Lomb (BLCO) | Canada | $7.041B | 30.30 |
| HealthEquity (HQY) | United States | $6.771B | 36.75 |
| PACS (PACS) | United States | $6.218B | 0.00 |
| Organon (OGN) | United States | $5.142B | 5.23 |
| Life Times (LTH) | United States | $4.879B | 40.78 |
| Sotera Health (SHC) | United States | $4.741B | 23.91 |
| Surgery Partners (SGRY) | United States | $4.088B | 45.30 |
| Concentras Parent (CON) | United States | $2.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.789B | 105.00 |
| BrightSpring Health Services (BTSG) | United States | $2.550B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.438B | 0.00 |
| Progyny (PGNY) | United States | $2.206B | 38.79 |
| Alignment Healthcare (ALHC) | United States | $2.177B | 0.00 |
| Premier (PINC) | United States | $2.052B | 9.23 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.921B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.778B | 8.93 |
| Agilon Health (AGL) | United States | $1.642B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.556B | 0.00 |
| CareDx (CDNA) | United States | $1.543B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.183B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.044B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.933B | 10.15 |
| Embecta (EMBC) | United States | $0.895B | 5.97 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.551B | 0.00 |
| Sharecare (SHCR) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Enhabit (EHAB) | United States | $0.410B | 35.48 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.361B | 13.58 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
| ModivCare (MODV) | United States | $0.192B | 6.11 |
| Beauty Health (SKIN) | United States | $0.187B | 0.00 |
| MultiPlan (MPLN) | United States | $0.152B | 0.00 |
| Nutex Health (NUTX) | United States | $0.126B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.081B | 19.72 |
| Singular Genomics Systems (OMIC) | United States | $0.042B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.66 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |